Discovery of 1‐(Cyclopropylmethyl)‐2‐(Dibenzo[b,d]Thiophen‐2‐yl)‐1H‐Benzo[d]Imidazole‐5‐Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist.
Saved in:
| Title: | Discovery of 1‐(Cyclopropylmethyl)‐2‐(Dibenzo[b,d]Thiophen‐2‐yl)‐1H‐Benzo[d]Imidazole‐5‐Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist. |
|---|---|
| Authors: | Kumar, Sanjay1,2 (AUTHOR), Chakraborty, Rajib1 (AUTHOR), Roy, Chandreyee1 (AUTHOR), Basu, Sohini1 (AUTHOR), Hajra, Arun K.1 (AUTHOR), Sen, Priyam1 (AUTHOR), Paul, Debajyoti1 (AUTHOR), Phukan, Karabi1 (AUTHOR), Roy, Subhasis1 (AUTHOR), Bera, Rammohan1 (AUTHOR), Mondal, Trisha1 (AUTHOR), Chakraborty, Sabyasachi1 (AUTHOR), Banerjee, Manish1 (AUTHOR), Mondal, Susanta K.1 (AUTHOR), Das, Sonali1 (AUTHOR), Malik, Pradip1 (AUTHOR), De Mandal, Surajit2 (AUTHOR), Subudhi, Enketeswara2 (AUTHOR) enketeswarasubudhi@soa.ac.in, Kundu, Mrinalkanti1 (AUTHOR) mrinal.kundu@tcgls.com |
| Source: | Chemical Biology & Drug Design. Jun2025, Vol. 105 Issue 6, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17470277 |
|---|---|
| DOI: | 10.1111/cbdd.70132 |
